Marco Meglio


First patient treated in adolescent epilepsy trial assessing NeuroPace RNS system

May 17, 2022

Since its approval for the treatment of medical refractory epilepsy in 2013, the closed-loop neuromodulation device has had its efficacy and safety confirmed in several pivotal studies and will now be assessed in focal epilepsy in the RESPONSE trial.